Back to Treatments

Treatment

Vedolizumab

3
Conditions
367
Trials
26K
Participants
58%
Average Safety

Condition Evidence

Crohn's Disease

95 trials · 6,000 participants

70% effectiveness · 50% safety

Inflammatory bowel disease

162 trials · 15K participants

80% effectiveness · 60% safety

Ulcerative Colitis

110 trials · 5,000 participants

75% effectiveness · 65% safety
Vedolizumab | DFDA